Success Metrics

Clinical Success Rate
75.0%

Based on 6 completed trials

Completion Rate
75%(6/8)
Active Trials
0(0%)
Results Posted
117%(7 trials)
Terminated
2(20%)

Phase Distribution

Ph phase_4
3
30%
Ph phase_2
3
30%
Ph not_applicable
4
40%

Phase Distribution

0

Early Stage

3

Mid Stage

3

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
3(30.0%)
Phase 4Post-market surveillance
3(30.0%)
N/ANon-phased studies
4(40.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

6 of 9 finished

Non-Completion Rate

33.3%

3 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(6)
Terminated(3)

Detailed Status

Completed6
Terminated2
Not yet recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (30.0%)
Phase 43 (30.0%)
N/A4 (40.0%)

Trials by Status

not_yet_recruiting110%
completed660%
withdrawn110%
terminated220%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10